Literature DB >> 22241572

Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families.

Yolanda Miroballi1, Elizabeth Garber, Haomiao Jia, Juyan Julia Zhou, Luis Alba, Lynne M Quittell, Denise Angst, Michael Cabana, Lisa Saiman.   

Abstract

BACKGROUND: In 2003, the Cystic Fibrosis (CF) Foundation in the United States published evidence-based infection control guidelines and distributed these to CF care centers. However, it is unclear how well the guidelines have been disseminated to patients and families, how well patients and families understand the principles of infection control, and what barriers they experience implementing the guidelines.
METHODS: We assessed infection control knowledge, attitudes, and practices among CF patients and their families at 17 randomly selected CF centers. Anonymous surveys were completed by CF patients (≥16 years old) or their family members (patients <16 years old). To adjust for similarities of patients within each center, generalized estimating equations regression was used.
RESULTS: From January 2007 to May 2009, 1,399 respondents completed surveys of whom 38% were patients and 62% were family members (overall mean age of patients = 14 years). Overall, 65% of respondents were aware of the CF infection control guidelines, but only 30% had discussed them more than once with their CF care team. More than one discussion was associated with increased knowledge of infection control, including routes of pathogen transmission; the importance of avoiding close contact with other CF patients; increased confidence in practicing infection control; and increased belief in the health benefits of infection control.
CONCLUSIONS: This study revealed that many CF patients and families are aware of the infection control guidelines, but that few had discussed them more than once with their CF teams. These findings underscore the importance of engaging patients and their families in regular discussions about infection control that address questions and concerns including the potential impact of infection control on health and well-being. Further strategies are needed to overcome barriers to implementing these guidelines.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22241572     DOI: 10.1002/ppul.21528

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  5 in total

Review 1.  Patient and public attitudes to and awareness of clinical practice guidelines: a systematic review with thematic and narrative syntheses.

Authors:  Kirsty Loudon; Nancy Santesso; Margaret Callaghan; Judith Thornton; Jenny Harbour; Karen Graham; Robin Harbour; Ilkka Kunnamo; Helena Liira; Emma McFarlane; Karen Ritchie; Shaun Treweek
Journal:  BMC Health Serv Res       Date:  2014-07-27       Impact factor: 2.655

Review 2.  Pro con debates in clinical medicine infection prevention and control in cystic fibrosis: One size fits all? The argument in favour.

Authors:  S Haggie; D A Fitzgerald
Journal:  Paediatr Respir Rev       Date:  2020-06-16       Impact factor: 2.726

3.  Environmental Microbial Contamination during Cystic Fibrosis Group-Based Psychotherapy.

Authors:  Martina Rossitto; Paola Tabarini; Vanessa Tuccio Guarna Assanti; Enza Montemitro; Arianna Pompilio; Ersilia Vita Fiscarelli
Journal:  Int J Environ Res Public Health       Date:  2021-01-28       Impact factor: 3.390

4.  Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa.

Authors:  R Somayaji; B Waddell; M L Workentine; M G Surette; N P Brager; H R Rabin; M D Parkins
Journal:  BMC Pulm Med       Date:  2015-11-05       Impact factor: 3.317

5.  Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers.

Authors:  Adriana Della Zuana; Doroti de Oliveira Garcia; Regina Célia Turola Passos Juliani; Luiz Vicente Ribeiro Ferreira da Silva Filho
Journal:  J Bras Pneumol       Date:  2014 Mar-Apr       Impact factor: 2.624

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.